Management

This page includes content on healthcare management, including health system, hospital, department and clinic business management and administration. Areas of focus are on cardiology and radiology department business administration. Subcategories covered in this section include healthcare economics, reimbursement, leadership, mergers and acquisitions, policy and regulations, practice management, quality, staffing, and supply chain.

When healthcare met politics with time running out: 3 new developments
The director of the National Institutes of Health and his principal deputy are touting their success at ‘curing’ the agency of its self-inflicted DEI disability.
FDA approves new nasal spray for patients with abnormal heart rhythms
Milestone Pharmaceuticals will be selling etripamil under the brand name Cardamyst. It is expected to hit the U.S. market in early 2026.
Philips to acquire AI-enabled intravascular imaging specialists SpectraWAVE
Massachusetts-based SpectraWAVE has gained considerable momentum in recent years, planting its flag in some of cardiology’s biggest trends. The company was co-founded by cardiologists and has already secured multiple FDA clearances.
American College of Radiology criticizes prominent study pushing for new approach to breast cancer screening
Published Friday in JAMA, scientists recently explored a risk-based mammography tactic that tailors regular imaging regimens to each individual’s danger of developing the disease.
Class action lawsuit claims imaging agent developer Telix Pharmaceuticals misled investors
Alleged transgressions took place between February and August, including the FDA rejecting Telix’s application for a new brain cancer imaging agent.

CMS’ move to reimburse doctors for imaging algorithm use is encouraging. But is it enough?

Some are calling on the agency to boost proposed payments for a tool that diagnoses diabetic retinopathy in order to encourage widespread adoption.

‘Lockdowns kill people’: Radiologist and White House COVID advisor Scott Atlas blasts colleagues

The neuroradiologist and fellow of Stanford’s Hoover Institution labeled fellow coronavirus counselor Anthony Fauci a "political animal" in a recent interview.

Pulmonary nodules following a lung transplant require ‘aggressive’ diagnostic evaluation, experts caution

Henry Ford providers recently detailed the rare case of a 70-year-old woman who developed a large nodule four years after the procedure.

Envision inks in-network radiology deal with Humana, Akumin’s Q3 earnings, plus more company news

Also, Irish teleradiology leader sells for almost $19 million, SimonMed's latest partnership, and New Jersey practice changes its name.

Top nuclear imaging group ‘strongly disagrees’ with Humana’s decision to refuse coverage for PET/CT

The Society of Nuclear Medicine and Molecular Imaging said the move denies patients access to potentially lifesaving technologies.

COVID-19 congress coronavirus Washington

Radiology among 74 medical groups pressing politicians to protect providers from ‘devastating’ pay cuts

ACR, SNMMI and others voiced their support this week for the “Holding Providers Harmless from Medicare Cuts During COVID-19 Act."

4 forces favoring, 5 working against Biden’s wish to lower Medicare eligibility age

President-elect Joe Biden wants to drop Medicare’s eligibility age to 60. If he succeeds, the move might bring in well more than 20 million new enrollees. What are the odds he’ll plant that piece of a potentially sweeping healthcare agenda?

Delaware cardiology practice to pay $500K to resolve fraud allegations

The alleged wrongdoings, reported by a whistleblower, occurred from April 2014 to March 2020.

Management

When healthcare met politics with time running out: 3 new developments

FDA approves new nasal spray for patients with abnormal heart rhythms

Philips to acquire AI-enabled intravascular imaging specialists SpectraWAVE

American College of Radiology criticizes prominent study pushing for new approach to breast cancer screening

Class action lawsuit claims imaging agent developer Telix Pharmaceuticals misled investors